Broad Pathogen Coverage — iDX Respiratory Gold (35 Pathogens)
iDX Respiratory Gold offers the market's broadest pathogen coverage, detecting 35 respiratory targets simultaneously including viruses, bacteria, and fungi. This panel detects both common and atypical infections, and is useful for OPD, ICU, and paediatric cases.
Helps differentiate viral vs bacterial infections, preventing antibiotic misuse. Includes viruses, bacteria, and fungi in a single comprehensive run.
Broad Pathogen Coverage
Covers 35 respiratory pathogens including common and atypical infections across viral, bacterial, and fungal categories.
Viruses
- Influenza A virus
- Influenza A-H1
- Influenza A-H1pdm09
- Influenza A-H3
- Influenza B virus
- Respiratory Syncytial Virus (RSV A & B)
- Rhinovirus / Enterovirus
- Human Metapneumovirus
- Parainfluenza virus 1
- Parainfluenza virus 2
- Parainfluenza virus 3
- Parainfluenza virus 4
- Bocavirus (1/2/3/4)
- Coronavirus 229E
- Coronavirus NL63
- Coronavirus OC43
- Coronavirus HKU1
- Adenovirus
- SARS-CoV-2
- Human Parechovirus (HPeV)
Bacteria
- Bordetella pertussis
- Chlamydophila pneumoniae
- Legionella pneumophila
- Mycoplasma pneumoniae
- Streptococcus pneumoniae
- Streptococcus pyogenes
- Haemophilus influenzae
- Moraxella catarrhalis
- Pseudomonas aeruginosa
- Streptococcus agalactiae
- Klebsiella pneumoniae
- Acinetobacter baumannii
- Staphylococcus aureus
Fungi
- Pneumocystis jirovecii
Working Hours: Monday-Saturday, 9:00 AM - 7:00 PM
iDX uses cellular sensor technology — eliminates any chances of false negative results.
Clinical Diagnostic Process
Using massive multiplexing, we analyze samples against 35 distinct genetic signatures in a single optimized run.
Why Choose iDX Respiratory Gold
- Covers 35 respiratory pathogens (Viral, Bacterial, Fungal)
- Helps differentiate viral vs bacterial infections
- Cellular sensor technology eliminates false negatives
- Broadest pathogen coverage available in the market
Your questions, answered clearly
Yes, it includes targets like Mycoplasma and Legionella which cause atypical infections.
Yes, it is highly recommended for critical care patients to identify coinfections quickly.
Yes, it includes Pneumocystis jirovecii detection.